News
Officials with the Food and Drug Administration are continuing to investigate several foodborne illness outbreaks. For an outbreak of E. coli O145:H28 ...
For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have ...
UC to invade Stanford's territory with large Peninsula campus This Peninsula biotech defied market trends with a cancer ...
The pending Nippon Steel deal would be unusual in granting the U.S. government some control over a private company—models ...
The latest addition to The Woodlands’ life sciences core is open for business, and it could attract more businesses to the ...
This startup’s mission to extend human life sounds like sci-fi, and investors are betting $20M on it
Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.
Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the ...
(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback